苏卡里比特智能手机应用程序用于更好地自我管理2型糖尿病:随机控制可行性研究
Cecilia Josefsson1, Thea Liljeroos2, Margareta Hellgren3
1Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
JMIR formative research
|January 10, 2024
概括
改善糖尿病自我护理的Sukaribit应用程序的可行性研究显示了有希望的招聘,但在家庭HbA1c测试和应用程序使用方面存在挑战. 为了进行更大规模的疗效研究,需要进一步改进.
科学领域:
- 数字健康干预措施 数字健康干预措施
- 糖尿病管理 糖尿病管理
- 可行性研究是可行性研究.
背景情况:
- 开发了一个新的移动应用程序Sukaribit,以促进护理人员和2型糖尿病患者之间的沟通.
- 该应用程序旨在增强患者的自我护理和改善血糖控制,通过血红蛋白A1c (HbA1c) 测量.
研究的目的:
- 评估Sukaribit应用程序干预和研究方法的可行性.
- 为了收集数据来规划一个更大,更强大的有效性研究.
主要方法:
- 进行了一项随机控制的可行性研究,采用混合方法设计.
- 患有2型糖尿病的成年人被随机分配到一个干预组 (n=28) 使用苏卡利比特2个月或接受标准护理的对照组 (n=31).
- 测量包括HbA1c,糖尿病困扰,体力活动和自我护理,可行性根据5个进展标准进行评估.
主要成果:
- 招聘超出预期;然而,在5个晋升标准中,只有2个符合.
- 自我报告的数据收集是成功的,但家庭HbA1c测试证明有问题.
- 干预组的每日血糖检测量略有增加 (每天增加0.6).
结论:
- 对于未来的研究,招募参与者似乎是可行的,但需要修改.
- 家庭HbA1c测试和预期的应用程序利用存在重大挑战,需要采用替代策略.
- 在进行更大的有效性试验之前,Sukaribit应用程序和研究程序需要大幅改进.
相关概念视频
Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Sulfonylureas
210
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
210
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects
175
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
175


